HAO Stock Forecast 2026-2027 - Haoxi Health Technology Ltd. Price Targets & Predictions

Ticker Nerd rank

HAO stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Haoxi Health Technology Ltd. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 8 Oct 2026

25 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size

99

Accruals

92

Volatility

62

Issuance

37

Growth

31

Revisions

25

Momentum

17

Value

13

Quality

12

Size (99): Smaller than most of the companies we track.

Quality (12): Profits are thin or unreliable for the size of the business, or they are not turning into cash.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

HAO stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on HAO, reported as data — targets and ratings, the market's view beside the model's.

We don’t hold enough price history for this company yet.

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. HAO appears on the weeks it earns a place.

Estimates

HAO analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

Haoxi Health Technology Ltd. (HAO) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation

Trailing P/E: 0.0×
Price / sales: 0.0×
Price / book: 0.0×
EV / EBITDA: 1.0×

Growth & margins

Revenue growth (YoY): 137.3%
Earnings growth (YoY): —
Gross margin: —
Operating margin: −11.8%
Net margin: −17.4%

Returns & dividend

Return on equity: −54.1%
Return on assets: −23.6%
Dividend yield: 1.4%

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Haoxi Health Technology Ltd. (HAO) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

Haoxi Health Technology Ltd. has a market value of $915K and an enterprise value of −$7.7M.
Shares outstanding: 464,404.
Trailing P/E: 0.0×.
Forward dividend yield: 1.45%, paying out 0% of earnings.
Haoxi Health Technology Ltd. employs 28 people.

market figures as at 9 Oct 2026

Data provided by Twelve Data

Peers

HAO vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelAdvertising Agencies

Company	Market cap	TKN rank
HAOHaoxi Health Technology Ltd.	$915,315.00	25
VSMEVS MEDIA Holdings Ltd.	$2.2M	47
DRCTDirect Digital Holdings, Inc.	$711,300.00	—
CHRCheer Holding, Inc.	$3.7M	12
YDKGYueda Digital Holding	$4.8M	15
CNETZW Data Action Technologies, Inc.	$5.4M	45
TDICDreamland Ltd.	$6.3M	9

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Haoxi Health Technology Ltd. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest HAO news & analysis

Haoxi Health Technology Limited Announces 1-For-20 Reverse Share Split

GlobeNewsWire · 12 Aug 2026neutral

Haoxi Health Technology Limited announced a 1-for-20 reverse share split of its outstanding Class A and Class B ordinary shares. The Class A Ordinary Shares will begin trading on a split-adjusted basis at the opening of Nasdaq on August 14, 2026.

Why it matters — The reverse share split changes HAO's share structure and trading basis, which HAO watchers will need to account for when tracking the stock beginning August 14, 2026.

FAQ

Frequently asked questions about HAO stock

How does Ticker Nerd's model rank HAO?

As at 8 Oct 2026, Haoxi Health Technology Ltd. ranks 25 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (99 of 100).

What is the HAO stock forecast for 2030?

No analyst covering Haoxi Health Technology Ltd. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for HAO are extrapolating price history, which says nothing about the business.

What does Haoxi Health Technology Ltd. do?

Haoxi Health Technology Limited Class A Ordinary Shares represent equity in Haoxi Health Technology Limited, a Beijing-based company that provides online marketing solutions in China. The company focuses on helping advertisers create and distribute digital ads across media platforms to acquire, convert, and retain consumers, with a particular emphasis on clients in the healthcare industry.

What is the latest news on HAO?

The most recent item we track (GlobeNewsWire, 12 Aug 2026): "Haoxi Health Technology Limited Announces 1-For-20 Reverse Share Split". Haoxi Health Technology Limited announced a 1-for-20 reverse share split of its outstanding Class A and Class B ordinary shares. The Class A Ordinary Shares will begin trading on a split-adjusted basis at the opening of Nasdaq on August 14, 2026.

Company

About Haoxi Health Technology Ltd.

Haoxi Health Technology Limited Class A Ordinary Shares represent equity in Haoxi Health Technology Limited, a Beijing-based company that provides online marketing solutions in China. The company focuses on helping advertisers create and distribute digital ads across media platforms to acquire, convert, and retain consumers, with a particular emphasis on clients in the healthcare industry. Its services are centered on performance-oriented marketing activities, including campaign planning, execution, and customer outreach through online channels. Haoxi Health Technology Limited operates through its subsidiaries and serves businesses that rely on targeted digital promotion to reach specific audiences. As a publicly traded equity class, the shares reflect ownership interests in the company’s current operating business rather than a standalone product or service.

CEO Mr. Zhen Fan · 28 employees · China · https://www.haoximedia.com